Professional Documents
Culture Documents
Preventing Stroke
Preventing Stroke
Preventing Stroke, Deep Vein Thrombosis and Pulmonary Embolism at Home Through
Anticoagulation Therapy
This capstone change proposal is classified under community since it is changing the
way individuals with deep vein thrombosis and pulmonary embolism are treated outside of
health facilities. DVT/PE are medical conditions caused by a clot forming in a conduit in the
for a prolonged time to minimize the development of additional thrombus (Patel, 2019). Most
of these condition's medications are only accessible in injectable version, which means they
can't be given at home. Low molecular weight heparin and unfractionated heparin are
Modern coagulation factors, like Pradaxa, Xarelto, and Eliquis, that block factors X as
well as 11a inhibitors, are authorized for usage. With exception of heparin and warfarin,
which should be checked continuously throughout the therapy duration to ascertain blood
Patients with deep vein thrombosis and pulmonary embolism have benefited from the advent
hospitalizations and outpatient visits, and improved treatment (Streiff et, al., 2016). Scientific
investigations and additional study should concentrate on the injectable versions for usage in
crisis situations like rapid commencement pulmonary embolism, which need immediate
medical attention.
2
References
Streiff, M., Agnelli, G., Connors, J., Crowther, M., Eichinger, S., & Lopes, R. et al. (2016).
10.1007/s11239-015-1317-0
Patel, K. (2019). Deep Venous Thrombosis (DVT) Treatment & Management: Approach
https://emedicine.medscape.com/article/1911303-treatment